SWOG S1216 is a clinical trial comparing standard hormonal therapy of LHRH + bicalutamide versus LHRH + TAK700. Attached is the ASCO abstract in this link.
advancedpcatalk.freeforums.net/thread/118/asco-abstract-s1216It's a very exciting time for me as this is a project I have had the opportunity to be a part of and now a co-author of the papers. It has been interesting to meet the other co-authors and work with them as well. It's a who's who of major institutional prostate cancer researchers and I am humbled to have my name next to theirs. But more importantly it's a meaningful clinical trial and I know a few that are participating right here at HW. But as I wrote it will take another 8 years to have the most meaningful information. But if things keep going as they are then maybe sooner is possible.